https://indianpedia.org/index.php?action=history&feed=atom&title=Kanneboyina_NagarajuKanneboyina Nagaraju - Revision history2026-08-01T06:08:50ZRevision history for this page on the wikiMediaWiki 1.45.4https://indianpedia.org/index.php?title=Kanneboyina_Nagaraju&diff=508285&oldid=prevJeffreyChallis6 at 15:36, 21 May 20242024-05-21T15:36:34Z<p></p>
<p><b>New page</b></p><div>{{Short description|Indian medical scientist and immunologist}}<br />
{{Use dmy dates|date=March 2019}}<br />
{{Use Indian English|date=March 2019}}<br />
{{Infobox academic<br />
| honorific_prefix =<br />
| name = Kanneboyina Nagaraju<br />
| honorific_suffix =<br />
| image =<br />
| image_size =<br />
| alt =<br />
| caption =<br />
| birth_name =<br />
| birth_date = <br />
| birth_place = [[India]]<br />
| residence =<br />
| nationality = <br />
| education = [[Sri Venkateswara Veterinary University]]<br />
[[Indian Veterinary Research Institute]]<br />
[[Sanjay Gandhi Postgraduate Institute of Medical Sciences]]<br />
| occupation =<br />
| years_active =<br />
| workplaces = [[National Institute of Health]]<br />
[[Johns Hopkins University School of Medicine]]<br />
[[Children's National Medical Center]]<br />
[[George Washington University School of Medicine]]<br>[[Binghamton University]]<br />
| known_for =<br />
| notable_works =<br />
| style =<br />
| home_town =<br />
| salary =<br />
| net_worth = <!-- Net worth should be supported with a citation from a reliable source --><br />
| height = <!-- {{height|m=}} --><br />
| weight = <!-- {{convert|weight in kg|kg|lb}} --><br />
| television =<br />
| title = Dean and SUNY Distinguished Professor<br />
| term =<br />
| boards =<br />
| religion = <!-- Religion should be supported with a citation from a reliable source --><br />
| denomination = <!-- Denomination should be supported with a citation from a reliable source --><br />
| spouse =<br />
| partner =<br />
| children =<br />
| parents =<br />
| relatives =<br />
| awards = <br />
| signature =<br />
| signature_alt =<br />
| signature_size =<br />
| website = <br />
| footnotes =<br />
}}<br />
'''Kanneboyina Nagaraju''' is the Dean of the School of Pharmacy and Pharmaceutical Sciences at the [[Binghamton University|State University of New York (SUNY), Binghamton]]. He holds the prestigious title of SUNY Distinguished Professor, the highest faculty rank awarded by the State University of New York system.<br />
<br />
Nagaraju is a renowned medical scientist and immunologist, known for developing the MHC Class I transgenic mouse model for autoimmune myositis.<ref>{{Cite journal|last1=Nagaraju|first1=K.|last2=Raben|first2=N.|last3=Loeffler|first3=L.|last4=Parker|first4=T.|last5=Rochon|first5=P. J.|last6=Lee|first6=E.|last7=Danning|first7=C.|last8=Wada|first8=R.|last9=Thompson|first9=C.|date=2000-08-01|title=Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies|journal=Proceedings of the National Academy of Sciences of the United States of America|volume=97|issue=16|pages=9209–9214|issn=0027-8424|pmid=10922072|pmc=16847|doi=10.1073/pnas.97.16.9209|doi-access=free}}</ref> He played a pivotal role in the identification and development of [[Vamorolone|Vamorolone (AGAMREE)]], a potent anti-inflammatory and membrane-stabilizing dissociated glucocorticoid with fewer side effects, in collaboration with Eric Hoffman and John McCall. Vamorolone has been approved by the Food and Drug Administration, the European Medicines Agency, and the Medicines and Healthcare Products Regulatory Agency for the treatment of children with Duchenne Muscular Dystrophy. Additionally, Nagaraju has led global initiatives to improve the rigor and reproducibility of preclinical drug trials and phenotyping in neuromuscular disease models.<ref>{{Cite journal|last1=Willmann|first1=Raffaella|last2=De Luca|first2=Annamaria|last3=Benatar|first3=Michael|last4=Grounds|first4=Miranda|last5=Dubach|first5=Judith|last6=Raymackers|first6=Jean-Marc|last7=Nagaraju|first7=Kanneboyina|last8=TREAT-NMD Neuromuscular Network|date=January 2012|title=Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice|journal=Neuromuscular Disorders|volume=22|issue=1|pages=43–49|doi=10.1016/j.nmd.2011.04.012|issn=1873-2364|pmc=3227750|pmid=21737275}}</ref><ref>{{Cite journal|last1=Willmann|first1=Raffaella|last2=Luca|first2=Annamaria De|last3=Nagaraju|first3=Kanneboyina|last4=Rüegg|first4=Markus A.|date=2015-05-14|title=Best Practices and Standard Protocols as a Tool to Enhance Translation for Neuromuscular Disorders|journal=Journal of Neuromuscular Diseases|volume=2|issue=2|pages=113–117|doi=10.3233/jnd-140067|pmid=27858730|issn=2214-3599|url=https://edoc.unibas.ch/58525/1/20170120134508_5882065487522.pdf}}</ref><ref>{{Cite journal|last1=Gordish-Dressman|first1=Heather|last2=Willmann|first2=Raffaella|last3=Dalle Pazze|first3=Laura|last4=Kreibich|first4=Arati|last5=van Putten|first5=Maaike|last6=Heydemann|first6=Ahlke|last7=Bogdanik|first7=Laurent|last8=Lutz|first8=Cathleen|last9=Davies|first9=Kay|date=2018|title="Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic|journal=Journal of Neuromuscular Diseases|volume=5|issue=4|pages=407–417|doi=10.3233/JND-180324|issn=2214-3599|pmc=6218134|pmid=30198876}}</ref><br />
<br />
== Education and career ==<br />
Nagaraju began his academic journey with veterinary training at [[Sri Venkateswara Veterinary University]] and the [[Indian Veterinary Research Institute]]. He then pursued a PhD in Immunology at the [[Sanjay Gandhi Postgraduate Institute of Medical Sciences]] and completed postdoctoral training in immunology at the [[National Institutes of Health]] (NIH). His academic career includes tenure-track and tenured positions at [[Johns Hopkins School of Medicine|Johns Hopkins University School of Medicine]], [[Children's National Hospital|Children's National Medical Center]], and [[George Washington University School of Medicine & Health Sciences|George Washington University School of Medicine]]. At SUNY Binghamton, he is a Professor of Pharmaceutical Sciences and the Founding Chair of the Department of Pharmaceutical Sciences. He has also served as Vice Dean of the School of Pharmacy and Pharmaceutical Sciences.<br />
<br />
Beyond academia, Nagaraju is an accomplished entrepreneur, co-founding ReveraGen BioPharma, which develops Vamorolone for inflammatory diseases, including muscular dystrophy, and AGADA BioSciences, which provides preclinical and clinical trial support services for therapeutics targeting rare neuromuscular diseases.<br />
<br />
==References==<br />
<references /><br />
<br />
==External links==<br />
* [https://scholar.google.com/citations?user=Ff5ZxYoAAAAJ&hl=en&oi=ao At Google Scholar]<br />
<br />
{{authority control}}<br />
<br />
{{DEFAULTSORT:Nagaraju, Kanneboyina}}<br />
[[Category:Indian immunologists]]<br />
[[Category:Sanjay Gandhi Postgraduate Institute of Medical Sciences alumni]]<br />
[[Category:Living people]]<br />
[[Category:Year of birth missing (living people)]]<br />
[[Category:George Washington University School of Medicine & Health Sciences faculty]]</div>JeffreyChallis6